NASDAQ · IXHL
Incannex Healthcare Limited
$2.58-$0.13 (-4.8%)
Incannex Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 82.7% below the high.
Loading market information…
ASX · AC8.AX · AUD
Stock price, dividends, earnings
Quote as of Jul 24, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
AusCann Group Holdings Ltd’s quoted price sits in the lower half of its reported 52-week range, 4.76% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
AusCann Group Holdings Ltd’s forward annual dividend is A$1.00 per share, paid annual. The forward yield is 2,500.0% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow AusCann Group Holdings Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in West Perth, Australia, AusCann Group Holdings Ltd currently lacks substantial business operations. Historically, the company specialized in the research, development, and commercialization of various therapeutic products derived from cannabinoids.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:55 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$2.58-$0.13 (-4.8%)
Incannex Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 82.7% below the high.
A$0.01A$0.00 (0.0%)
Creso Pharma Limited’s quoted price sits in the lower half of its reported 52-week range, 83.02% below the high.
A$0.03+A$0.00 (+3.7%)
Pharmaxis Ltd’s quoted price sits in the lower half of its reported 52-week range, 56.92% below the high.
$8.72+$0.39 (+4.68%)
Kazia Therapeutics Ltd ADR’s quoted price sits in the lower half of its reported 52-week range, 49.89% below the high.
A$0.04A$0.00 (0.0%)
CardieX Limited’s quoted price sits in the lower half of its reported 52-week range, 79.43% below the high.
A$0.42+A$0.01 (+2.44%)
MGC Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 96.18% below the high.
A$0.01+A$0.00 (+22.22%)
1st Group Limited’s quoted price sits in the upper half of its reported 52-week range, 26.67% below the high.
A$6.60A$0.00 (0.0%)
Medlab Clinical Limited: Healthcare · Biotechnology.
